Does Higher Quality of Care in SLE Translate to Better Patient Outcomes? acrabstracts.org/abstract/does-…

Experience from a Diverse Rheumatology Cohort with COVID-19: Are We Doing Better Than We Expected? acrabstracts.org/abstract/exper…

#ACR21 The Great Debate: Belimumab vs Voclosporin as Add-On Therapy in #LupusNephritis | Dr. Petri & Dr. Rovin Audience Vote 🗳: What would you add to mycophenolate first? Belimumab 71%, Voclosporin 29% #ACRAmbassador American College of Rheumatology Summary of Pros & Cons of Each⬇️

🏆🏆🏆🏆🏆Congratulations to our Chair Dr. Joel Block in being honored with the most prestigious ACR Masters award 🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆

We are happy to launch C-COMP, a new NIAMS funded P30 to study mechanisms underlying pain in rheumatic and musculoskeletal diseases @rem7101 Richard J. Miller More information coming soon!

Red flags for #VEXAS diagnosis ⚠️Systemic inflammation ⚠️Multiorgan ⚠️Macrocytic anemia, MDS and/or thrombocytopenia ⚠️Neutrophilic dermatosis or leukocytoclastic vasculitis ⚠️Nasal and/or auricular chondritis ⚠️Pulmonary infiltrates ⚠️Thrombosis 👉🏾journals.lww.com/co-rheumatolog…

Summary of treatments in psoriatic arthritis #PsA Dr. John Cush #ACR24

Excellent overview of #PsA t/t by Dr. Ana-Maria Orbai 👉 high yield summaries for Axial, Dactylitis, Enthesitis, Nail disease & peripheral arthritis! (A boatload of hard work putting these together 🙏🏼) #ACR24 #ACRambassador American College of Rheumatology

#Calcinosis is tough to treat! Here’s a nice summary of options to consider in #Scleroderma & #DM including biologics (RTX in SSc and Tofacitinib in DM) and Minocycline 👉 Needs individualizing! Excellent talk by Dr. Valenzuela #ACR24 #ACRambassador #ReviewCourse American College of Rheumatology

Metabolic bone dz By Laura Carbone (2/3) Elevated BMD Z > +2.5 Focal = bone mets, fracture, SAPHO, OA, Pagets, AS, DISH Diffuse = Osteopetrosis, Hep C associated osteosclerosis (cranial sparing), MF, mastocytosis #ACR24

Classification of Idiopathic Inflammatory Myositis #MedX

Upadacitinib (UPA), a new oral treatment option for GCA? Dr. Peter Merkel discusses SELECT-GCA. UPA15 + 26-week GC taper >> PBO with a 52-week GC taper for GCA remission. #ACR24 #ACRBest Dr. John Cush ABST#0770

🔶Clinical Year in Review #ACR24 🔶 Talk By Michael Pillinger • Review some of the most impactful studies in Rheumatology from the past year! #RheumTwitter #Rheumatology

#1156 Didem Saygin, MD et al finds that ~1/3 patients with myositis have comorbid fibromyalgia ➡️Presence of fibromyalgia significantly impacted patient global disease activity #acr24 Dr. John Cush

Thank you for the highlight and glad to finally meet in person with #RheumChampion Cheryl Crow, Arthritis Life #ACR24 Rheumatology Research Foundation

#ACR24 Lupus Nephritis  • By Dr. Maria Dall'Era UCSF Rheumatology Review of #LupusNephritis 🫘 ▪️Rx TRIPLE therapy ▪️belimumab vs voclosporin ▪️low level proteinuria (even *UPCR <0.5*) can STILL be associated with disease activity (Class III/IV/V) #Lupus #RheumTwitter #NephTwitter